All published articles of this journal are available on ScienceDirect.
The Effect of SITERDUGA on Family Anxiety: A Quasi-Experimental Study
iD
Putu Intan Daryaswanti2
iD
Ni Luh Putu Thrisna Dewi1
iD
A.A Sri Sanjiwani1
Ni Luh Putu Dewi Puspawati1
iD
I Nyoman Dharma Wisnawa3
Yupin Aungsuroch4
iD
Authors Info & Affiliations
Abstract
Background
Family Caregivers (FCG) play a crucial role in the recovery process of individuals with Severe Mental Disorders (SMDs). The negative stigma against people with SMDs and their families leads to their isolation, which results in insufficient support from the family in the recovery process. FCGs who care for members with SMD are at risk of experiencing anxiety. This condition requires proper management. Moreover, the use of Android-based applications is growing in parallel with the increasing use of smartphones in daily life, and these applications can address psychological issues.
Objective
The purpose of this study was to analyze the effect of the SITERDUGA application on the anxiety levels of FCGs caring for people with SMD.
Methods
This study employed a quasi-experimental design with pre-test and post-test control groups. The study was conducted from September to November 2024 in Denpasar City, Indonesia. The population of people with SMDs was 231 people. The sampling technique was purposive sampling, with a sample of 80 people divided into two groups of 40 participants each. The participants were assigned to each group randomly. The study measured anxiety levels using the STAI-T questionnaire. The intervention group then received training using the application SITERDUGA (Integrated Information System for the Movement to Support and Accept People with Mental Disorders in the Family). The application consists of RISA (Mental Health Information Room), NOTA (Care Notification), AKTA (Family Modality Activity), and DETIK (Family Integrated Emotional Support).
Results
The results of this study showed a change in anxiety levels among respondents before and after the intervention using the SITERDUGA application. In the intervention group, the p-value was 0.000, while the control group had a p-value of 0.051, meaning no change occurred without treatment. The intervention provided through the comprehensive approach, such as the SITERDUGA application, was able to reduce the anxiety experienced.
Conclusion
The SITERDUGA application could be a useful guide to support families in taking care of patients with SMD.
